Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Balch

Showing results (61-70 of 224) with videos related to

Pageof 23
Sort By:
Journal of the American College of Surgeons|August 17, 2000
Second-time surgery for stage IV sarcoma (a model of sequential metastases)C M Balch, D L Morton
Journal of the American College of Surgeons|August 7, 1999
The importance of lymphatic anatomy in melanoma--a resurgence of clinical significance in an era of sentinel lymph node technologyC M Balch, M I Ross
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1988
Adjuvant therapy for node-negative breast cancer patients. Who benefits?C M Balch, S E Singletary
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Finally, a successful adjuvant therapy for high-risk melanomaC M Balch, A C Buzaid
Oncology (Williston Park, N.Y.)|November 1, 1988
Three unresolved issues in the surgical treatment of melanomaA W Boddie, C M Balch
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 19, 2015
Uncertainties in the management of melanoma nodal metastasisO Zoras, K Lasithiotakis, C M Balch
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1982
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capabilityT Abo, M D Cooper, C M Balch
Scandinavian Journal of Immunology|January 1, 1980
Immunochemical characterization of a human B lymphocyte differentiation antigen (p65)E W Ades, S Ferrone, C M Balch
Cancer Research|June 1, 1986
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomasK Itoh, A B Tilden, C M Balch
Cellular Immunology|August 1, 1988
Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferationK Itoh, C M Balch, C D Platsoucas
Pageof 23

Showing results (61-70 of 224) with videos related to

Sort By:
Pageof 23
Journal of the American College of Surgeons|August 17, 2000
Second-time surgery for stage IV sarcoma (a model of sequential metastases)C M Balch, D L Morton
Journal of the American College of Surgeons|August 7, 1999
The importance of lymphatic anatomy in melanoma--a resurgence of clinical significance in an era of sentinel lymph node technologyC M Balch, M I Ross
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1988
Adjuvant therapy for node-negative breast cancer patients. Who benefits?C M Balch, S E Singletary
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Finally, a successful adjuvant therapy for high-risk melanomaC M Balch, A C Buzaid
Oncology (Williston Park, N.Y.)|November 1, 1988
Three unresolved issues in the surgical treatment of melanomaA W Boddie, C M Balch
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 19, 2015
Uncertainties in the management of melanoma nodal metastasisO Zoras, K Lasithiotakis, C M Balch
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1982
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capabilityT Abo, M D Cooper, C M Balch
Scandinavian Journal of Immunology|January 1, 1980
Immunochemical characterization of a human B lymphocyte differentiation antigen (p65)E W Ades, S Ferrone, C M Balch
Cancer Research|June 1, 1986
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomasK Itoh, A B Tilden, C M Balch
Cellular Immunology|August 1, 1988
Monocyte-independent interleukin-2 production and proliferation of human T cells in response to murine hybridomas expressing the OKT3 monoclonal antibody: interleukin-1 is not required for T-cell proliferationK Itoh, C M Balch, C D Platsoucas
Pageof 23